New Cochrane Review assesses evidence on different ways to reduce consumption of sugary drinks

'Cochrane exists so that healthcare decisions get better.’ That is the first sentence of our Strategy to 2020 that aims to put Cochrane evidence at the heart of health decision-making all over the world. Here’s a look back at some key highlights of our work in the first quarter of 2019, from January to March.

This Friday (31st May, 2019) will mark my final day as your Editor in Chief. I want to express my gratitude to you all for your forbearance, support, challenge and friendship over these past 10 years. Believe me when I say that having the privilege of serving you all has been the highlight of my working life. Life has never been easy, but I have learned such a great deal from you, had experiences I couldn’t have imagined, and found myself stretched (in a good way) every day.

The Cochrane Rapid Review Methods Group is leading an important piece of methodological research and need your help.

International Clinical Trials' Day is celebrated in 2019 on 20 May marking the day in 1747 on which James Lind is believed to have begun the first known controlled trial, comparing different treatments for scurvy which was common among sailors in the British Royal Navy.

Cochrane does not make clinical recommendations, instead it provides unbiased and high-quality health evidence so that health decisions, policies, and clinical guidelines can be informed by the best available evidence. ‘Cochrane Evidence in Everyday Life’ series collects stories about individuals, families, and carers making health decisions based on Cochrane evidence. Each piece in the series collects stories around the personal impact that one Cochrane Review has made.

The Governing Board is delighted to announce that, with effect from 1 June 2019, Dr. Karla Soares-Weiser will become the new Editor in Chief of the Cochrane Library. Karla will replace current Editor in Chief Dr. David Tovey, who is stepping down from the role at the end of May following ten years of distinguished service.

New evidence published today in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.Nicotine replacement therapy (NRT) is a medicine that is available as skin patches, chewing gum, nasal and

‘Cochrane at the WHO' is a blog series that highlights the partnership between Cochrane and the World Health Organization. If you would like to share a story about how your Cochrane Group is working with WHO, please contact Emma Thompson, Advocacy and Partnership Officer.